A New Model for Collaboration

Four strategic recommendations for disruptive innovators in biopharma businesses are as follows: Partner aggressively to develop assets...

John Q Leonard

Sep 3, 20143 min read

Roche's Kadcyla Outstrips Marginal Utility in UK

An innovative new cancer drug shown to extend the lives of women with breast cancer by an average of 6 months has recently crossed an...

John Q Leonard

Aug 20, 20142 min read

The biotech and pharmaceutical industries are currently in the midst of consolidation, and new opportunities for disruption are arising...